Search

everythinglearnresearchcommunity

for

Search:↓

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

DPCP can help regrow hair in some people with severe alopecia.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

Divalproex sodium can unexpectedly cause agitation and hyperactivity in some patients.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Divalproex sodium can sometimes worsen behavior in some patients.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Polydeoxyribonucleotide (PDRN) may help lighten skin and treat hyperpigmentation.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

DPCP is effective for treating severe alopecia areata, but relapse is common.

5alpha-DHP may be a safe, effective treatment for certain seizures without causing sedation.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.